Allergic Reactions After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Allergic Reactions After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Early safety monitoring of the Pfizer-BioNTech COVID-19 vaccine has detected 21 cases of anaphylaxis after reported administration of 1,893,360 first doses of Pfizer-BioNTech COVID-19 vaccine (11.1 cases per million vaccine... read more

Ivermectin for COVID-19, Breakthrough Treatment or Hydroxychloroquine Redux?

Ivermectin for COVID-19, Breakthrough Treatment or Hydroxychloroquine Redux?

It’s an indisputable fact that we need better treatments for COVID-19. This is particularly true in the outpatient setting. Let’s count how many we have today, hmm, this shouldn’t take long. That would be zero —... read more

Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19

Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19

Primary outcome in the RECOVERY trial and in the WHO REACT meta-analysis was 28-day mortality. Assessing 28-day mortality may not be the optimal outcome in a trial. Since patients with severe COVID-19 often require prolonged... read more

The COVID-19 Vaccine: An Expert’s Medical Guide for All

The COVID-19 Vaccine: An Expert’s Medical Guide for All

Vaccine expert Zeil Rosenberg, M.D. shares his medical knowledge, backed by scientific data, about the development, safety and effectiveness of the new COVID-19 vaccines. Dr. Rosenberg M.D. is a Board-Certified Preventive... read more

Harmonizing Heterogeneous Endpoints in COVID-19 Trials Without Loss of Information

Harmonizing Heterogeneous Endpoints in COVID-19 Trials Without Loss of Information

All ongoing clinical trials should include a stacked probability plot in their statistical analysis plan as descriptive analysis. While primary analysis should be on an early endpoint with appropriate capability to be... read more

Lactoferrin for the Treatment of COVID‑19

Lactoferrin for the Treatment of COVID‑19

The coronavirus disease 2019 (COVID‑19) outbreak was caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). The clinical outcomes of elderly individuals and those with underlying... read more

Modifiable Factors Associated With Chronic Pain After Surgery for Distal Radius Fractures

Modifiable Factors Associated With Chronic Pain After Surgery for Distal Radius Fractures

In this study, preoperative pain, time to surgery, and procedure type were modifiable factors associated with chronic pain 1 year after DRF treated with surgery. Adequate pain control in patients with acute DRFs even... read more

Childhood sepsis deadlier for Black patients

Childhood sepsis deadlier for Black patients

In this large, representative analysis of paediatric severe sepsis in the USA, we found evidence of outcome disparities by race or ethnicity and insurance status. Our findings suggest that there might be differential... read more

Evaluation and Treatment of Renal and Perinephric Abscesses

Evaluation and Treatment of Renal and Perinephric Abscesses

A 30-year-old woman with past medical history of type 2 diabetes presents to the emergency department with 3 days of vague abdominal/back pain, with associated subjective fever, chills, nausea and vomiting. She states she... read more

PEM Playbook – Pediatric Pain

PEM Playbook – Pediatric Pain

Pain is multifactorial: it is comprised of physical, psychological, emotional, cultural, and contextual features. In children often the predominant feature may not be initially apparent.  Although clinicians may focus on... read more

ED Evaluation and Management of Non-Obstetric Abdominal Pain in the Pregnant Patient

ED Evaluation and Management of Non-Obstetric Abdominal Pain in the Pregnant Patient

A 27-year-old G4P2 female at 25-weeks gestation presents to the emergency department with right upper quadrant abdominal pain. The pain began yesterday and was initially a generalized discomfort that localized to the right... read more

Apoptotic cells for therapeutic use in cytokine storm associated with sepsis

Apoptotic cells for therapeutic use in cytokine storm associated with sepsis

Sepsis has no proven specific pharmacologic treatment. Reported mortality in sepsis ranges from 30%-45%. This study was designed to determine the safety preliminary efficacy of allogenic apoptotic cells administered for immunomodulation... read more

Caring for the Sickest COVID-19 Patients: An ICU Story

Caring for the Sickest COVID-19 Patients: An ICU Story

In an article for the latest issue of Stanford Medicine magazine, I provide a glimpse into the journey Free and his front-line Stanford Health Care colleagues took -- from Day 1 through the following weeks and months -- to... read more

COVID-19 and ARDS: The Baby Lung Size Matters

COVID-19 and ARDS: The Baby Lung Size Matters

COVID-19 in its initial manifestations has strikingly peculiar characteristics (e.g., hypoxemia with vasocentric injury and high gas lung volume), is so evident that atypical ARDS should not be a matter of further discussion.... read more